|
|
|
Moderna taps into AWS to boost Covid-19 vaccine research
|
|
|
|
Top Stories |
|
|
|
|
IANS | 06 Aug, 2020
The biotechnology major Moderna which has entered the phase III clinical
trials for its Covid-19 vaccine has selected Amazon Web Services (AWS)
as its preferred Cloud partner as well as its standard for analytics and
Machine Learning (ML) workloads.
Moderna is pioneering a new class of messenger RNA (mRNA) medicines.
Leveraging
its mRNA platform and manufacturing facility with the AWS-powered
research engine, Moderna delivered the first clinical batch of its
vaccine candidate (mRNA-1273) against COVID-19 to the NIH for the Phase I
trial, 42 days after the initial sequencing of the virus.
"The
science behind mRNA medicines is advancing at a rapid pace, and building
Moderna's technology platform on AWS gives our scientists the insights,
agility, and security they need to continue to lead in the industry,"
said Stephane Bancel, Moderna's Chief Executive Officer.
"With
AWS, our researchers have the ability to quickly design and execute
research experiments and rapidly uncover new insights to get potentially
life-saving treatments into production faster," Bancel said in a
statement late on Wednesday.
Moderna has invented proprietary
technologies and methods that run on AWS to create mRNA constructs that
cells recognize as if they were produced in the body.
This
invention has empowered Moderna to experiment rapidly on virtually any
mRNA sequence, easily shifting between research priorities, without
investing in new technology.
In addition, by leveraging Amazon
Redshift – AWS's fully managed data warehousing service – Moderna's
scientists and engineers aggregate results from dozens of experiments
that are running in parallel and can easily query and share insights to
refine their design and production cycle quickly.
"Running on
AWS, Moderna has the agility to continuously refine its research,
development, and manufacturing," said Matt Garman, Vice President, Sales
and Marketing at AWS.
"Moderna is relying on the proven
performance and scale of the world's leading cloud to innovate and
develop drug and vaccine candidates on timelines that may have been
impossible even just a few years ago."
|
|
|
|
|
|
|
|
|
|
|
|
|
Customs Exchange Rates |
Currency |
Import |
Export |
US Dollar
|
66.20
|
64.50 |
UK Pound
|
87.50
|
84.65 |
Euro
|
78.25
|
75.65 |
Japanese
Yen |
58.85 |
56.85 |
As on 13 Aug, 2022 |
|
|
Daily Poll |
|
|
PM Modi's recent US visit to redefine India-US bilateral relations |
|
|
|
|
|
Commented Stories |
|
|
|
|
|
|
|
|